Loading people...
Christoph Boehringer is an Investor and Managing Director at CD-Venture and a Member of the Shareholders' Committee at Boehringer Ingelheim, based in Munich, Germany. Through CD-Venture, he directs seed and Series A venture capital investments into a growing portfolio of more than 10 early-stage technology and digital health startups across the European ecosystem. As a member of the founding family behind Boehringer Ingelheim, he helps oversee one of the world's largest privately held pharmaceutical corporations, an international enterprise employing tens of thousands of people globally. His professional background bridges traditional corporate governance with digital transformation, frequently collaborating with academic and research institutions like the Technical University of Munich to identify emerging industrial innovations. Boehringer currently focuses on deploying strategic venture capital into life sciences, biotechnology, and deep tech enterprises that modernize the broader healthcare sector.
Christoph Boehringer stands as a distinguished investor at CD-Venture, a leading venture capital firm renowned for its strategic investments in groundbreaking companies. In his pivotal role, Christoph is instrumental in shaping CD-Venture's portfolio, meticulously identifying and backing innovative startups poised for significant market disruption and sustainable growth. His expertise lies in recognizing nascent opportunities and providing the crucial capital and strategic guidance necessary for early-stage companies to scale and thrive.
At CD-Venture, Christoph Boehringer's investment focus spans a diverse range of high-growth sectors. He is particularly keen on companies at the forefront of technological advancement, including artificial intelligence, enterprise software as a service (SaaS), biotechnology, fintech, and sustainable technologies. Christoph seeks out ventures that not only present compelling business models but also possess strong leadership teams and a clear vision for addressing critical market needs. His approach is hands-on, often working closely with founders to refine their strategies, navigate challenges, and accelerate their path to market leadership.
Christoph's career background is marked by a deep understanding of both finance and innovation. Prior to his tenure at CD-Venture, he cultivated extensive experience in various capacities within the investment landscape, honing his analytical skills and developing a keen eye for identifying undervalued assets and emerging trends. This rich history has equipped him with a comprehensive perspective on market dynamics and the intricacies of building successful enterprises from the ground up. While specific notable investments are often confidential in the venture capital world, Christoph has a track record of contributing to the success of several high-impact ventures that have gone on to achieve significant milestones and exits.
His commitment extends beyond mere capital injection; Christoph Boehringer is a firm believer in fostering an ecosystem of innovation. He actively engages with the entrepreneurial community, sharing insights and mentorship to empower the next generation of founders. Through CD-Venture, he continues to champion companies that are not only financially promising but also have the potential to create lasting positive societal and economic impact. His strategic foresight and dedication make him a vital asset to CD-Venture and a respected figure in the global investment community.
Christoph Boehringer is a prominent investor at CD-Venture, a venture capital firm. He is known for identifying and supporting high-potential startups across various innovative sectors.
Christoph Boehringer primarily invests in companies leveraging disruptive technologies, including AI, SaaS, biotechnology, fintech, and sustainable technologies. He seeks ventures with strong leadership and clear market solutions.
Christoph Boehringer works as an investor at CD-Venture, a leading venture capital firm that focuses on strategic investments in groundbreaking companies.